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Abstract
Purpose Increased nociceptive activity and the experience of exercise-induced pain (EIP) may contribute to fatigue during 
endurance exercise. To investigate this, a pain model that produces pain similar to EIP and decouples its relationship to exer-
cise intensity is required. This study (1) compared the quality of pain caused by a hypertonic saline injection into the vastus 
lateralis in resting and exercise conditions, and (2) investigated whether this pain contributes to changes in time to task failure.
Methods On separate days, 18 participants completed a time to task failure at 20% maximal voluntary torque (MVT), a 
resting hypertonic saline intramuscular injection, and in a further three visits a time to task failure at 10% MVT following 
injection of isotonic saline, hypertonic saline or a control (no injection).
Results In a subset of eligible participants (n = 12), the hypertonic saline combined with 10% MVT produced a qualitative 
experience of pain (assessed by the McGill Pain Questionnaire) that felt similar to EIP. 10% MVT with hypertonic saline 
significantly elevated pain intensity in the first 20% of the time to task failure and caused a significantly (P < 0.05) shorter 
time to task failure (448 ± 240 s) compared with the isotonic saline (605 ± 285 s) and control (514 ± 197 s) conditions.
Conclusion These findings demonstrate that hypertonic saline increases the intensity of pain during exercise, which results 
in a faster occurrence of exercise-induced fatigue. These results provide important evidence supporting pain as a limiting 
factor in endurance performance.
Keywords Endurance · Exercise-induced pain · Fatigue · Hypertonic saline · Isometric · Nociception
Abbreviations
ANOVA  Analysis of variance
EIP  Exercise-induced pain
HR  Heart rate
HYP  Hypertonic saline
ISO  Isotonic saline
MPQ  McGill Pain Questionnaire
MVC  Maximal voluntary contraction
MVT  Maximal voluntary torque
PANAS  Positive and negative affect schedule
PRI(T)  Pain rating index (total)
RF  Rectus femoris
RPE  Rating of perceived exertion
SD  Standard deviation
sEMG  Surface electromyography
SRI  Subclass rating index
VAS  Visual analogue scale
VL  Vastus lateralis
VM  Vastus medialis
Introduction
Intense and prolonged muscle contractions result in acute 
pain proportional to the intensity and duration of exercise 
(Cook et al. 1997). This ‘exercise-induced pain’ (EIP) arises 
from the sensitisation and activation of ascending group III 
and IV nociceptive afferents in response to the accumula-
tion of endogenous algesics and increases in noxious and 
mechanical pressure within the contracting skeletal muscu-
lature (O’Connor and Cook 1999). The experience of EIP 
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is often accompanied by fatigue (Pollak et al. 2014), which 
is defined as an exercise-induced reduction in the capac-
ity to produce muscle force or power (Bigland-Ritchie and 
Wood 1984). This association has led to the suggestion that 
EIP may accelerate fatigue development during intense and 
prolonged exercise (Mauger 2014).
In support of this notion, the stimulation of muscle noci-
ceptors and increased muscle afferent activity has demon-
strated significant reductions in voluntary activation of the 
elbow flexors (Kennedy et al. 2013) and maximal voluntary 
force of the knee extensors (Graven-Nielsen et al. 2002). 
Furthermore, partial blockade of group III and IV muscle 
afferents at the spinal level results in the attenuation of per-
ceived fatigue, and increases central motor drive (Amann 
et al. 2009). Based on these findings, it is suggested that the 
increased activation of group III and IV afferents inhibits 
central motor drive and the ability to recruit motor units 
(Amann et al. 2011; Hureau et al. 2019).
A challenge in studying the fatigue–pain relationship 
(Mauger 2013; Pollak et al. 2014) is that most experimen-
tal pain-induction methods are notably different in their 
processing and response compared with the transmission 
and experience of EIP [i.e. differences in the neurological 
processes that result in the perception of pain, from trans-
duction to perception (Olesen et al. 2012)]. For example, 
ischemic, electrical and thermal pain induction are experi-
mental pain models that are non-specific to the muscle, and 
can also induce the perception of cutaneous pain (Staahl and 
Drewes 2004; Olesen et al. 2012). The additional stimulation 
of these superficial tissues can produce a subjective pain 
quality described as “sharp” or “stabbing” as opposed to 
the “aching” or “cramping” nature of muscle pain (Mense 
1993). As such their use may be inappropriate in the inves-
tigation of EIP.
Consequently, an experimental model that induces mus-
cle pain that feels like naturally occurring EIP and allows 
its contribution to fatigue to be investigated by decoupling 
EIP from exercise intensity is desirable. The intramuscular 
injection of hypertonic saline is a well-established and safe 
experimental method that, under resting conditions, induces 
standardised and reproducible acute pain often described as 
‘aching’ and ‘cramping’ (Graven-Nielsen et al. 1997a, b, c). 
When injected, this solution activates predominantly group 
IV afferents with some contribution from myelinated group 
III nerve fibres (Laursen et al. 1999), which is similar to the 
nociceptive pathway of EIP (O’Connor and Cook 1999).
However, whilst hypertonic saline is established for 
inducing muscle pain, there has been limited comparison 
with the experience of EIP and minimal application to 
explore the fatigue–pain relationship. Indeed, in this field 
hypertonic saline is most widely used to investigate putative 
pain-induced changes to motor control (Hodges and Tucker 
2011), maximal voluntary contraction (Graven-Nielsen et al. 
2002), and high-intensity, short-duration exercise perfor-
mance (Graven-Nielsen et al. 1997d) rather than its impact 
on exercise-induced fatigue. In addition, the exercise intensi-
ties, durations, and muscle groups used in these studies have 
limited relevance to exercise conditions where the impact 
of EIP on fatigue is most prominent [i.e. prolonged dura-
tion (> 2 min), exhaustive exercise in large, primary muscle 
groups involved in locomotive exercise] (Cook et al. 1997; 
Abbiss and Laursen 2008).
Therefore, the aims of this study were to (i) compare the 
qualitative experience (based on the total and subclass scores 
from the McGill Pain Questionnaire) of naturally occurring 
EIP to the pain elicited from an intramuscular injection of 
hypertonic saline into a locomotor muscle; and (ii) identify 
the effects of the muscle pain elicited by this method on the 
performance time of an endurance exercise task. We tested 
the hypothesis that the addition of an intramuscular injection 
of 5.8% hypertonic saline into the vastus lateralis (VL) to 
low-intensity exercise (i) produces a similar quality of pain 
(as defined by the McGill Pain Questionnaire) compared to 
naturally occurring EIP caused by a higher exercise inten-
sity; and (ii) results in a shorter time to task failure compared 
to placebo and control conditions.
Methods
Ethical approval
The School of Sport and Exercises (University of Kent) 
Research Ethics Advisory Group (Prop 84_2016_17) 
approved all procedures and protocols in accordance with 
the Declaration of Helsinki. Written informed consent was 
gained from the participants prior to participation.
Participants
Eighteen healthy and recreationally active participants (11 
male, 7 female; mean ± SD: age, 24.5 ± 4.0 years; height 
1.76 ± 0.1 m; body mass 73.9 ± 13.4 kg; physical activity 
5.5 ± 2.3 h·w−1) volunteered to participate in the present 
study. The sample size was estimated based on the effect size 
reported in a similar exercise and pain study (Deschamps 
et al. 2014) to satisfy statistical power at 80%. All partici-
pants attended each visit in a similar psychological state 
as assessed by the Positive and Negative Affect Schedule 
(PANAS) (Watson et al. 1988), which was completed at the 
start of each visit.
Participants with existing knee pain, cardiorespiratory 
disease, neurological disorders, blood-borne viruses (e.g. 
hepatitis B/C and HIV), sore deep tissues, phobia to nee-
dles and any allergy were excluded from the study. Par-
ticipants consuming supplements or medications that alter 
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pain perception during the course of the study were also 
excluded. Before each visit, participants were instructed 
to refrain from vigorous exercise (24 h) and abstain from 
the consumption of alcohol (48 h), analgesics (6 h) and 
caffeine (8 h).
Experimental procedures
Participants attended the laboratory on five occasions, 
with each visit separated by 2–7 days. In the initial visit, 
anthropometric measures were recorded, and partici-
pants were familiarised with all measures relating to the 
experimental protocol, including a practice of knee exten-
sor maximal voluntary contractions (MVCs). Five min-
utes after the MVCs, participants performed an isomet-
ric time to task failure (TTF) at 20% maximal voluntary 
torque (MVT). In visit 2, participants received a single 
injection of hypertonic saline (Rest HYP), whilst seated 
at rest (see “Intramuscular injection procedure”). Upon 
the completion of the injection, participants were asked 
to continuously rate muscle pain intensity, with the visit 
concluding once the participant had returned to the state 
of ‘no pain’. In a further three visits (visits 3–5), partici-
pants performed a TTF at 10% MVT in three conditions 
in the presence of no injection (10% MVT, control), iso-
tonic saline (10% MVT + ISO, placebo) and hypertonic 
saline (10% MVT + HYP). In the 10% MVT + ISO and 
10% MVT + HYP visits, an intramuscular injection was 
administered prior to the TTF, with the task commencing 
within 3 s of needle removal. Conditions were performed 
in a single-blind, randomised and counter-balanced order.
Time to task failure (TTF) protocol
All visits were performed seated on an isokinetic dynamom-
eter (Cybex HUMAC Norm isokinetic dynamometer; CSMi, 
Soughton, MA, USA), set up for the right leg with knee 
angle at 75° flexion (0° = full extension of the knee), and 
a hip angle at 90°. At the start of each visit, participants 
completed a 5 min self-paced, submaximal warm-up on a 
cycle ergometer (Wattbike Ltd, Nottingham, UK) followed 
by 3 × 3 s MVCs separated by 90 s rest. The highest torque 
produced across the three MVCs was defined as the MVT. 
The TTF commenced 5 min after the MVCs, with the partic-
ipants directed to maintain a submaximal isometric contrac-
tion of the right knee extensors. The participants received 
visual feedback of the target torque on a computer screen 
but were unaware of the overall time elapsed. The task was 
limited to a maximum of 20 min, or was terminated when 
the torque fell below the target for more than 3 s. Within 3 s 
of task cessation participants performed a final MVC.
Intramuscular injection procedure
A single bolus of 1.0 mL 5.8% hypertonic saline was injected 
in the VL (middle third of the lateral aspect of the thigh) of 
the right leg to induce acute muscle pain. Injection of a sin-
gle bolus of 1.0 mL 0.9% isotonic saline was implemented 
as a placebo. The injection was performed manually in a 
20 s window (10 s infusion period) using a 3-mL Luer-Lok 
syringe connected to a 25 G × 38 mm SurGuard2 disposable 
stainless needle (Terumo, Japan).
Perceptual measurements
At the start of each visit, participants were asked to rate (on a 
visual analogue scale) how much pain they expected to expe-
rience (anchored to the non-injury pain experienced dur-
ing exercise) (0 = “no pain” to 10 = “worst possible pain”) 
and their confidence to cope with the expected level of pain 
(0 = “not confident at all” to 10 = “completely confident”). 
This provides a measure of pain-specific self-efficacy which 
is believed to a predictor of pain tolerance and endurance 
(Motl et al. 2007; Schmitz et al. 2013). Two characteris-
tics of pain were evaluated: intensity and quality. During all 
visits, pain intensity was continuously scored on a moment-
to-moment basis using an electronic visual analogue scale 
(VAS) ranging from 0 (“no pain”) to 10 (“extremely intense 
pain”) (Cook et al. 1997) and anchored to previous expe-
riences of naturally occurring EIP (Astokorki and Mauger 
2017). The device automatically sampled and recorded the 
reported pain intensity every 5 s, which allowed for values 
such as VAS onset (the time-point at which the stimulus 
is first perceived to be greater than “no pain”) peak pain 
intensity (VAS peak), time to maximal intensity (from the 
commencement of sampling), mean pain intensity (the mean 
VAS from the commencement of sampling until task fail-
ure), duration of pain (from VAS onset until the state of 
“no pain”), and VAS area (area under VAS curve) to be 
calculated.
The quality of pain was established by the long-form 
McGill Pain Questionnaire (MPQ) (Melzack 1975) which 
contains a total of 20 categories of adjectives describing four 
major subclasses of pain experience (sensory, affective, eval-
uative and miscellaneous). Each category contains between 
two and six similar adjectives arranged in ascending order 
of implied pain intensity and is assigned rank value based on 
this order (e.g. the descriptor associated with the least pain 
within the category is assigned a value of 1). Participants 
were permitted to select a maximum of one word per cat-
egory (should any of the descriptors apply). The descriptors 
chosen by the participants were subsequently summed to cal-
culate scores for each subclass (Subclass Rating Index) and 
the total score of all subclasses (Total Pain Rating Index), 
with the overall quality of pain expressed by descriptors 
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chosen by more than one-third of participants. The MPQ 
was completed after the post-TTF MVC in each visit, and 
the return to “no pain” in the Rest HYP visit.
During all of the TTF trials at 10% MVT (visits 3–5), 
participants also reported Rating of Perceived Exertion 
(RPE), defined as the effort to drive the limb (Pageaux et al. 
2015), using the 15-point Borg (6–20) scale (Borg 1998) 
every 30 s. Rating of Fatigue, the perceived inability of the 
muscle to produce torque, was recorded every 30 s for the 
first min, and every 60 s thereafter using the 11-point Rating 
of Fatigue (ROF) scale (Micklewright et al. 2017).
Physiological measurements
During the TTFs at 10% MVT (visits 3–5) heart rate (HR) 
was recorded every 30 s using a Polar FT1 HR monitor 
paired with a coded T34 transmitter (Polar, Polar Electro, 
Kempele, Finland), and muscle electrical activity was con-
tinuously recorded using surface electromyography (sEMG). 
sEMG was acquired with square surface electrodes (Ag/
AgCl, 32 × 32 mm; Nessler Medizintechnik, Innsbruck, Aus-
tria) mounted in a bipolar setup on skin which was shaven 
and cleansed with an alcohol swab. Electrodes were placed 
over the muscle belly of the VL, rectus femoris (RF) and 
vastus medialis (VM) in the direction of the muscle fibres, 
with a reference electrode placed on the patella. The electri-
cal signal was sampled at 2000 Hz (Biopac MP150, Biopac 
Systems Inc., California, USA) and acquired in Spike2 soft-
ware (Version 7; Cambridge Electronic Design).
The sEMG data were analysed using custom code writ-
ten in MATLAB R2018a (The MathWorks, Massachusetts, 
USA). To create a linear envelope representation of the data, 
the raw sEMG signals were rectified by taking the absolute 
values, and two-pass zero-lag filtered using a fourth-order 
low-pass Butterworth filter with a cut-off frequency of 5 Hz. 
To analyse changes over time, the signals were divided into 
10 s epochs. The mean sEMG amplitude for the VL, RF 
and VM over each 10 s epoch was extracted and normalised 
to the maximum sEMG amplitude of the prior MVCs (% 
MVC).
Statistical analysis
All data are presented in the form of mean ± standard devia-
tion (SD). Prior to statistical analysis, all data were checked 
for the assumptions associated with a paired samples t test, 
a one-way ANOVA and a repeated measures ANOVA as 
appropriate. Data that did not satisfy the Shaprio–Wilk test 
of normality (P < 0.05) were logarithmically transformed. 
The Bonferroni post-hoc correction was applied where 
appropriate. Cohen’s d and partial eta square (ƞp2) values 
are reported as measures of effect size (Cohen 1988).
Due to between subject variability in TTF, an ‘individual 
iso-time’ approach as outlined by Nicolò et al. (2019) was 
applied to compare perceptual (pain intensity, RPE, ROF) 
and physiological (HR, sEMG) variables. The shortest TTF 
for each participant was used to identify four (RPE, ROF, 
HR) and ten (pain intensity and sEMG) time-points in which 
the three conditions were segmented. This approach main-
tains a majority of the time-series data (i.e. allows for the 
inclusion of all repeated recordings such as pain, RPE and 
ROF to be included) and provides a consistent number of 
data points to allow comparison between participants for all 
stated variables across the varying TTF times.
A two-way ANOVA with treatment factor with three fixed 
levels (10% MVT, 10% MVT + ISO, 10% MVT + HYP) and 
a repeated measures time factor with 10 time-points were 
used to test the effect of condition and time on pain inten-
sity and sEMG during the TTF. Two-way ANOVAs with 
a treatment factor with three fixed levels (10% MVT, 10% 
MVT + ISO, Experimental) and a repeated measures time 
factor with 4 time-points were used for measures of RPE, 
ROF and HR recorded during the TTF. When an interac-
tion effect was observed, post-hoc paired sample t tests were 
implemented to evaluate differences between conditions. 
Statistical significance was accepted at an alpha level of 
P < 0.05 except where a Bonferroni correction was applied 
(adjusted, P < 0.0042). All statistics were performed using 
SPSS Statistics v24.0 (SPSS, IBM, New York, USA).
Results
As the TTF task was limited to a maximum of 20 min, par-
ticipants that met this cut-off in any condition did not reach 
task failure or ‘exhaustion’, which does not provide a true 
indication of endurance performance. To account for this, 
these participants (n = 6) were subsequently removed from 
the dataset, and analysis was performed on the subset of 
participants (n = 12).
Comparison of pain intensity and quality
Mean TTF at 20% MVT was 193 ± 50  s. As shown in 
Table 1, paired samples t tests revealed a significant dif-
ference in VAS scores between pain intensity during 20% 
MVT TTF and experimental muscle pain from rest HYP 
(P < 0.05). The 20% MVT task induced a significantly 
greater mean VAS, equivalent to between “somewhat 
strong” and “strong” pain intensity (t11 = 5.3, P < 0.001,  CI.95 
1.1, 2.6, d = 1.8), which peaked after a longer period of time 
(t11 = 5.6, P < 0.001,  CI.95 64, 147, d = 1.7) and lasted for a 
shorter duration (t11 = − 3.9, P = 0.002,  CI.95 − 175, − 49, 
d = 1.7) than the experimental muscle pain experienced in 
rest HYP.
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Differences in VAS scores were also reported between 
20% TTF and the TTFs at 10% MVT (P < 0.05). The VAS 
onset was significantly slower in 10% MVT (t11 = − 5.0, 
P < 0.001,  CI.95 − 44, − 17, d = 1.0) and 10% MVT + ISO 
(t11 = − 2.3, P = 0.043,  CI.95 − 33, − 1, d = 0.7), with a 
quicker onset in 10% MVT + HYP (t11 = 2.2, P = 0.0047, 
 CI.95 0.2, 29, d = 0.9). A greater VAS mean, equivalent to 
between “strong” and “very strong” pain, was observed in 
the 10% MVT + HYP condition compared to 20% MVT 
(t11 = − 2.8, P = 0.017,  CI.95 − 2.6, − 0.3, d = 1.1) and 10% 
MVT (t11 = − 2.3, P = 0.044,  CI.95 − 1.97, − 0.03, d = 0.6).
The VAS in all three conditions performed at 10% MVT 
peaked after a longer period of time (10% MVT; t11 = − 6.5, 
P < 0.001,  CI.95 − 344, − 170, d = 2.0, 10% MVT + ISO; 
t11 = − 4.9, P < 0.001,  CI.95 − 484, − 185, d = 1.7, 10% 
MVT + HYP; t11 = − 3.5, P = 0.005,  CI.95 − 321, − 74, 
d = 1.2) and lasted longer in duration (10% MVT; t11 = − 6.3, 
P < 0.001,  CI.95 − 394, − 189, d = 2.2, 10% MVT + ISO; 
t11 = − 5.6, P < 0.001,  CI.95 − 538, − 234, d = 2.0, 10% 
MVT + HYP; t11 = − 4.2, P = 0.001,  CI.95 − 411, − 130, 
d = 1.6) than the 20% MVT condition. This contributed 
to a greater VAS area (10% MVT; t11 = − 5.4, P < 0.001, 
 CI.95 − 2551, − 1077, d = 1.9, 10% MVT + ISO; t11 = − 5.9, 
P < 0.001,  CI.95 − 3233, − 1466, d = 2.2, 10% MVT + HYP; 
t11 = − 4.4, P = 0.001,  CI.95 − 2754, − 929, d = 1.7) in the 
10% MVT conditions compared to 20% MVT.
Overall, as shown in Table 2, the dimensional quality of 
pain experienced during 20% MVT was similar to rest HYP 
for the sensory (P = 0.123) and miscellaneous (P = 0.189) 
dimensions, but not for the affective (P = 0.008) and evalu-
ative (P = 0.007) subclasses. The 20% MVT task produced 
a greater mean Total Pain Index of 30 ± 11 (t11 = 2.9, 
P = 0.016,  CI.95 2, 18, d = 0.7) than rest HYP (20 ± 9), and 
as shown in Table 2, and was defined by descriptives rep-
resenting all dimensions in the MPQ. However, the 10% 
MVT + HYP condition, with a mean total pain index of 
29 ± 14, produced a similar overall subjective quality of 
pain to 20% MVT (t11 = 0.3, P = 0.743,  CI.95 − 6, 8, d = 0.1). 
Paired samples  t tests revealed no significant difference in 
Subclass Rating Index between 10% MVT + HYP and 10% 
MVT (Sensory; P = 0.704, Affective: P = 0.429, Evalua-
tive; P = 0.878; Miscellaneous, P = 0.410) as well as 10% 
MVT + HYP and 20% MVT (Sensory; P = 0.941, Affective: 
P = 0.394, Evaluative; P = 0.504; Miscellaneous, P = 0.810) 
for all classifications (Table 2).
Time to task failure (TTF)
An ANOVA revealed a significant difference between 
conditions (F2,22 = 6.7, P = 0.005, ƞp2 = 0.378) with 10% 
MVT + HYP causing a significantly (t11 = 3.4, P = 0.006, 
 CI.95 55, 257, d = 0.6) shorter TTF (448 ± 240 s) compared 
to both 10% MVT + ISO (605 ± 285  s), and 10% MVT 
(514 ± 197 s) (t11 = 2.3, P = 0.040,  CI.95 4, 127, d = 0.3) 
(Fig. 1a). No significant differences were observed between 
10% MVT and 10% MVT + ISO (t11 = − 1.8, P = 0.104,  CI.95 
− 204, 22 d = 0.4).
Paired samples t tests showed that post-TTF MVT sig-
nificantly decreased in 10% MVT (pre = 304 ± 56 N.m, 
post = 191 ± 62 N.m), 10% MVT + ISO (pre = 300 ± 62 N.m, 
pos t  =  197  ± 64   N.m)  and  10% MVT + HYP 
(pre = 308 ± 65 N.m, post = 187 ± 66 N.m) in comparison 
to pre-TTF MVT (P < 0.001). No significant difference was 
observed between conditions for absolute decrement in 
MVT (F2,22 = 1.0, P = 0.379, ƞp2 = 0.204). An ANOVA also 
demonstrated no significant difference between conditions 
for positive affect (F2,22 = 1.8, P = 0.189, ƞp2 = 0.141), and 
negative affect (F2,22 = 1.4, P = 0.263, ƞp2 = 0.114) recorded 
prior to the TTF.
Pain intensity
An ANOVA revealed a significant difference in pain 
expectations between conditions (F2,22 = 9.6, P = 0.001, 
ƞp2 = 0.467), but not in confidence to cope with the expected 
pain (F2,22 = 2.3, P = 0.125, ƞp2 = 0.172). Subsequent pair-
wise comparisons found greater expectations of pain in 10% 
MVT + ISO (7.2 ± 1.9) (t11 = − 3.8, P = 0.003,  CI.95 − 2, 
Table 1  Summary VAS scores 
from 20% MVT, Rest HYP, 
10% MVT, 10% MVT + ISO, 
10% MVT + HYP TTF
Values are means ± SD
* Significantly different vs 20% MVT (P < 0.05)
** Significantly different vs 20% MVT (P < 0.001)
† Significantly different vs 10% MVT (P < 0.05)
20% MVT Rest HYP 10% MVT 10% MVT + ISO 10% MVT + HYP
VAS onset (s) 25 ± 22 7 ± 16 55 ± 36** 42 ± 29* 10 ± 9*
VAS mean 4.8 ± 1.0 3.0 ± 1.0** 5.3 ± 1.4 5.5 ± 1.2 6.3 ± 1.7*†
VAS peak 9.7 ± 0.7 5.8 ± 2.1** 9.5 ± 0.8 9.0 ± 1.5 9.2 ± 1.6
VAS time to peak (s) 181 ± 51 75 ± 31** 438 ± 171** 516 ± 282** 379 ± 229*
VAS duration (s) 168 ± 42 281 ± 84* 459 ± 185** 555 ± 270** 438 ± 241*
VAS area 899 ± 315 869 ± 386 2713 ± 1282** 3248 ± 1493** 2740 ± 1521*
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− 1, d = 0.7) and 10% MVT + HYP (7.5 ± 1.3)(t11 = − 4.5, 
P = 0.001,  CI.95 − 2, − 1, d = 1.0) compared to 10% MVT 
(6.0 ± 1.6) with no significant difference between 10% 
MVT + ISO and 10% MVT + HYP (t11 = − 0.7, P = 0.518, 
 CI.95 − 1, 1, d = 0.2).
The 3 × 10 (condition × iso-time) repeated meas-
ures ANOVA highlighted a significant effect of condi-
tion (F2,22 = 6.5, P = 0.006, ƞp2 = 0.372) and iso-time 
(F2.8,31.2 = 82.2, P < 0.001, ƞp2 = 0.882) for perceived pain 
during the TTF (Fig. 1b). A significant interaction effect 
for pain over iso-time between conditions during the TTF 
was observed (F3.9,42.4 = 3.4, P = 0.018, ƞp2 = 0.236). Follow-
up targeted paired-sample t tests with a Bonferroni correc-
tion revealed a significantly greater VAS pain intensity at 
10% iso-time (43 ± 21 s) in 10% MVT + HYP compared to 
both 10% MVT (t11 = − 6.4, P < 0.001,  CI.95 − 43.7, − 21.3, 
d = 1.9) and 10% MVT + ISO (t11 = − 5.8, P < 0.001,  CI.95 
− 44.2, − 19.9, d = 1.9) and at 20% iso-time (86 ± 42 s) in 
contrast with 10% MVT (t11 = − 4.3, P = 0.001,  CI.95 − 42.1, 
− 13.4, d = 1.3) and 10% MVT + ISO (t11 = − 6.3, P < 0.001, 
 CI.95 − 38.9, − 18.6, d = 1.5).
Perceptual measurements
The 3 × 4 (condition × iso-time) repeated measures ANOVA 
revealed no significant main effect of condition for ROF or 
RPE (P > 0.05). Both ROF and RPE had a significant effect 
of iso-time (ROF; F1.4,15.9 = 104.1, P < 0.001, ƞp2 = 0.904, 
RPE; F1.5,16.3 = 87.8, P < 0.001, ƞp2 = 0.889), and an inter-
action effect (ROF; F2.1,23.4 = 6.9, P = 0.004, ƞp2 = 0.387, 
RPE; F2.8,31.1 = 4.6, P = 0.010, ƞp2 = 0.296) (Fig. 1c, d). Fol-
lowup paired samples t tests with a Bonferroni correction 
(P > 0.004) revealed no significant differences at any iso-
time point between conditions for both ROF and RPE.
Surface electromyography (sEMG)
Due to a loss in sEMG signal, two participants were 
removed from the dataset and analysis was performed 
on the remaining participants (n = 10). A 3 × 10 (condi-
tion × iso-time) repeated measures ANOVA demonstrated 
no significant main effect of condition in either the VL 
(F2,18 = 1.3, P = 0.288, ƞp2 = 0.129), VM (F2,18 = 1.9, 
P = 0.174, ƞp2 = 0.177) or RF (F2,18 = 0.5, P = 0.613, 
ƞp2 = 0.053). A significant effect of iso-time in the activ-
ity of the VL (F1.5,13.2 = 19.3, P < 0.001, ƞp2 = 0.682), 
VM (F1.8,16.4 = 14.2, P < 0.001, ƞp2 = 0.612), and RF 
(F2.0,18.2 = 6.7, P = 0.007, ƞp2 = 0.426) was reported 
(Fig. 2). There was no interaction effect observed in the 
RF (F18,162 = 0.4, P = 0.994, ƞp2 = 0.037). A significant 
interaction effect was reported for VL (F18,162 = 3.5, 
P < 0.001, ƞp2 = 0.278) and VM (F18,162 = 2.2, P = 0.006, 
Table 2  Frequently selected words from the MPQ subclasses
The frequently selected words from the MPQ are shown with the percentage of participants that selected these words. Data on Subclass Rating 
Index (SRI) and Pain Rating Index (Total) presented as Mean ± SD
* Significantly different vs 20% MVT (P < 0.05)
Subclass 20% MVT REST HYP 10% MVT 10% MVT + ISO 10% MVT + HYP
Throbbing (33%) Throbbing (50%) Lacerating (33%) Throbbing (50%) Throbbing (58%)
Sharp (58%) Shooting (42%) Cramping (58%) Cramping (41%) Drilling (33%)
Cramping (33%) Sharp (33%) Pulling (33%) Burning (50%) Cramping (67%)
Pulling (33%) Cramping (67%) Searing (33%) Aching (67%) Burning (42%)
Hot (33%) Aching (67%) Aching (50%) Aching (50%)
Burning (33%) Tender (33%) Heavy (33%)
Hurting (33%)
Sensory Aching (58%)
SRI 18 ± 6 15 ± 6 18 ± 9 15 ± 6 18 ± 9





SRI 3 ± 3 1 ± 1* 3 ± 2 2 ± 2 3 ± 2
Evaluative Intense (50%) Intense (33%) Intense (58%) Intense (67%) Intense (67%)




SRI 5 ± 4 3 ± 3 4 ± 3 5 ± 4 5 ± 4
PRI(T) 30 ± 11 20 ± 9* 28 ± 12 26 ± 11 29 ± 14
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ƞp2 = 0.195) activity over iso-time between conditions; 
however, subsequent followup-targeted paired sample t 
tests with a Bonferroni correction demonstrated no sig-
nificant differences (Fig. 3a–c).
Heart rate (HR)
The 3 × 4 (condition × iso-time) repeated measures 
ANOVA revealed no significant main effect of condi-
tion (F1.3,14.1 = 0.8, P = 0.404, ƞp2 = 0.071). There was a 
significant effect of iso-time (F1.1,12.3 = 39.6, P < 0.001, 
ƞp2 = 0.783), and an interaction effect for HR and iso-
time between conditions during the TTF (F1.7,18.9 = 6.0, 
P = 0.012, ƞp2 = 0.352). Subsequent paired samples t tests 
with a Bonferroni correction revealed no significant dif-
ferences between conditions (Fig. 3d).
Discussion
This study confirms that the pain experienced during knee 
extensor exercise at 10% MVT can be made to feel like that of 
a higher exercise intensity, through the intramuscular injection 
of hypertonic saline into the VL. Using this intervention, exer-
cise-induced fatigue occurred more rapidly, with participants 
reaching task failure earlier when exercising with a greater 
pain intensity (Fig. 1b). This study therefore provides indica-
tive evidence to support the notion that pain is a significant 
factor affecting endurance exercise performance.
Fig. 1  Performance and perceptual differences between conditions. 
Differences in  TTF  between conditions (a), and pain intensity (b) 
and RPE (c) and ROF (d) over iso-time between conditions dur-
ing the TTF. *Significant difference between conditions (P < 0.05). 
**Significant difference between 10% MVT + HYP and 10% MVT 
(P ≤ 0.001). #Significant difference between 10% MVT + HYP and 
10% MVT + ISO (P < 0.001). §Significant main effect of iso-time
 European Journal of Applied Physiology
1 3
Hypertonic saline combined with light exercise feels 
like EIP
The novel question the present study strived to answer was 
whether the addition of hypertonic saline to light intensity 
exercise at 10% MVT produces an elevated pain intensity 
which also feels similar to the naturally occurring EIP dur-
ing a higher exercise intensity (20% MVT). Thus, the first 
key finding from this study is that when combined with 
light exercise (10% MVT), the hypertonic saline induced 
a descriptive quality of pain similar to the EIP from both 
the 10% and 20% MVT exercise tasks (but with a higher 
Fig. 2  Torque and sEMG data during the TTF of the 10% MVT (a), 10% MVT + ISO (b) and 10% MVT + HYP (c) conditions for a representa-
tive participant. The TTF was significantly shortened in the 10% MVT + HYP condition
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intensity). This is in contrast to the administration of hyper-
tonic saline at rest, where our findings were consistent with 
the established literature — a ‘moderate’ to ‘somewhat 
strong’ pain, described as ‘cramping’, ‘aching’, ‘throbbing’ 
and ‘intense’ (Graven-Nielsen et al. 1997a, b, c). Further-
more, in these resting conditions, whilst the sensory and 
miscellaneous quality of experimental pain was similar to 
the naturally occurring EIP experienced during the 20% 
MVT task, there were differences in pain intensity and 
quality. In particular, the 20% MVT task produced a higher 
pain intensity that was also described in the affective (e.g. 
‘exhausting’) dimension. This suggests that for hypertonic 
saline to induce a pain that feels like EIP, it needs to be com-
bined with at least light intensity exercise. When this was 
done, participants experienced an elevated overall intensity 
of pain (compared to both 10% and 20% MVT) but were 
unable to distinguish between the experimental muscle pain 
produced by the hypertonic saline and the EIP from the 
muscular contraction. The findings of this study therefore 
provide support for this hypertonic saline model for uncou-
pling the exercise intensity and EIP relationship (Cook et al. 
1997) — i.e. causing a light exercise intensity to feel like a 
harder exercise intensity.
Effect of pain on isometric TTF
The present study demonstrates that greater levels of pain 
in a fresh, undamaged, large locomotor muscle group sig-
nificantly shortens TTF during an isometric endurance 
task. Indeed, TTF was significantly shorter in the 10% 
MVT + HYP condition than both the 10% MVT and 10% 
MVT + ISO conditions, with an impaired performance of 
12 to 26%. As all conditions were performed at the same 
intensity (10% MVT) and with participants in a similar 
psychological state, these differences in TTF can be attrib-
uted solely to increasing the experience of pain in the 10% 
MVT + HYP condition, as clearly shown in Fig. 1b.
Previous research that has used hypertonic saline to 
induce muscle pain have predominantly applied it in 
smaller muscles or muscle groups (e.g. biceps brachii, 
tibialis anterior and gastrocnemius (Graven-Nielsen et al. 
1997d; Ciubotariu et al. 2004; Khan et al. 2011)) and have 
not focused on producing a pain experience that feels like 
Fig. 3  Physiological differences between conditions. EMG of the VL (a), VM (b) and RF (c) over iso-time between conditions during the TTF. 
HR differences between conditions over iso-time during the TTF (d). §Significant main effect of iso-time (P < 0.05)
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EIP. The VL is a large muscle with a key role in the gen-
eration of force during basic locomotor tasks (e.g. walking, 
stair climbing) and contributes to propulsive energy during 
cycling (Raasch et al. 1997), as well as the stance and swing 
phase in running (Sasaki and Neptune 2006). Understanding 
the effects of an increased overall pain experience in this 
muscle (and surrounding knee extensor group) at a contrac-
tion intensity utilised during cycling exercise (Löllgen et al. 
1980) therefore provides information that closely translates 
to exercise performance and a clinical context. Care should 
however be taken when extrapolating findings to whole-body 
exercise or dynamic contraction.
During the impaired TTF performance in the 10% 
MVT + HYP condition, pain intensity was significantly 
elevated in the first 20% of the task, with a continued lin-
ear increase until task failure. Indeed, the intensity of pain 
reported in the 10% MVT + HYP condition was elevated 
by approximately 3.3 at 10% iso-time and 2.8 at 20% iso-
time on the VAS scale. The hypertonic saline in the 10% 
MVT + HYP condition would have increased the activa-
tion of the group III and IV nociceptive afferents in addi-
tion to the rapidly increasing noxious environment arising 
from the metabolites produced as a result of the exercise 
task (O’Connor and Cook 1999), which might explain the 
shorter TTF in the 10% MVT + HYP condition.
This explanation is in accordance with the “Sensory 
Tolerance Limit”, where in open-loop exercise tasks (i.e. 
TTF) the increased inhibitory feedback from Group III and 
IV afferents contributes to an individual and task-specific 
threshold, which when reached the exercise is voluntarily 
terminated (Amann and Dempsey 2008; Amann 2011). With 
similar values for RPE and ROF between conditions, it is 
likely the elevated pain intensity during the TTF at 10% 
MVT + HYP resulted in this sensory tolerance limit being 
reached sooner, causing a faster occurrence of task failure 
compared to the 10% MVT and 10% MVT + ISO conditions 
(Aboodarda et al. 2020).
In addition, the increased nociceptive activity (a specific 
type of afferent feedback) may have limited central motor 
drive and voluntary activation of the knee extensors (Amann 
et al. 2009, 2011; Aboodarda et al. 2020), a notion which 
is supported by evidence showing a relationship between 
group III and IV muscle afferents and neuromuscular fatigue 
(Amann et al. 2015; Sidhu et al. 2018). In support of this, 
Henriksen and colleagues (2011) reported a reduced capac-
ity of the knee extensors to produce an MVT in the presence 
of pain. Furthermore, findings from Graven-Nielsen and col-
leagues (2002) demonstrated that experimental muscle pain 
(from the hypertonic saline model) reduces MVT despite an 
unaffected twitch torque, implying that performance decre-
ments were due to mechanisms residing in the central nerv-
ous system rather than the peripheral musculature (Graven-
Nielsen et al. 2002).
Rather than a uniform inhibitory/facilitatory effect on 
agonist and antagonist muscle activity (Pain Adaptation 
Model, Lund et al. 1991), it is now recognised that pain 
does not cause uniform inhibition/excitation effects across 
the motor neurone pool, but instead causes a redistribution 
of activity within and between muscles (Hodges and Tucker 
2011). Accordingly, the decreased performance caused by 
the overall increased pain experience in the current study 
could also be explained by a slight change in the direction of 
knee extensor torque to a more lateral/medial plane (Tucker 
and Hodges 2010). In this context, the gross feature of the 
task would remain (i.e. knee extension), but the efficiency of 
this movement would be compromised. Motor unit recruit-
ment order, or a recruitment of larger units at lower torques, 
could have also affected the task performance. In an endur-
ance task lasting several minutes, the preferential recruit-
ment of large high threshold motor units (which may include 
Type II muscle fibres) above low threshold small motor units 
(Type I muscle fibres) would likely have consequences for 
the rate at which fatigue occurs (both metabolic and neu-
ral), leading to a shorter TTF (Edwards 1981). Whilst not 
observed in the present study, an increase in sEMG would 
be indicative of an increased central drive to the muscle and/
or an increased recruitment of high threshold motor units 
(Gerdle et al. 2000), which would be in line with Hodges 
and Tucker’s “moving differently in pain” theory (Hodges 
and Tucker 2011).
Methodological considerations
The methods used in this study preclude the ability to iden-
tify which, or combination of these mechanisms, may have 
contributed to the shorter TTF. Indeed, combinations of 
peripheral nerve/transcranial stimulation, multiple force 
transducers, and fine wire electrodes would be required for 
this. In addition, the sensitivity of the sEMG setup in the 
present study did not allow for the detection of non-uniform 
changes across the motor neurone pool (i.e. any alterations 
are unlikely to be discovered with bipolar sEMG). As such, 
an approach that allows for the identification of individual 
motor units would be more appropriate for the observation 
of subtle changes in activity within and between the mus-
cles (i.e. high-density EMG). Differential responses to pain 
between male and female participants are also acknowl-
edged, with the present study not accounting for or attempt-
ing to control the menstrual cycle of the female participants. 
Indeed, hormonal changes across the different phases of the 
menstrual cycle may cause some difference in pain percep-
tion to experimental pain (Sherman and LeResche 2006).
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Conclusion
The injection of hypertonic saline into the VL during a sus-
tained low-intensity isometric contraction provides an over-
all qualitative experience of pain that feels like naturally 
occurring EIP induced by a higher intensity exercise. When 
applied to submaximal exercise, this additional pain caused 
a shorter TTF compared with a placebo and control condi-
tion. It is plausible that the mechanisms responsible for the 
shorter TTF were related to increased activity of group III 
and IV nociceptive afferents from the injected muscle. The 
present study therefore provides important evidence that 
muscle pain has a direct impact on endurance performance.
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